Quoin Pharmaceuticals (QNRX) Assets Average (2018 - 2026)
Quoin Pharmaceuticals (QNRX) posted Assets Average of $18.0 million for Q1 2026, up 34.57% sequentially from $13.4 million in Q4 2025, and up 25.88% YoY from $14.3 million in Q1 2025.
Quoin Pharmaceuticals (QNRX) Assets Average (2018 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Assets Average for 8 years, with the latest figure at $18.0 million in Q1 2026.
- Quarterly Assets Average rose 25.88% year-over-year to $18.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.0 million (up 25.88% YoY) and the FY2025 annual result came in at $18.0 million, up 29.49% from the prior year.
- Assets Average advanced to $18.0 million in Q1 2026 per QNRX's latest filing, from $13.4 million in the prior quarter.
- Over five years, Assets Average peaked at $18.0 million in Q1 2026 and troughed at $7.7 million in Q3 2025.
- A 5-year average of $14.0 million and a median of $14.1 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2025: Assets Average surged 53.07% in 2023, then tumbled 39.72% in 2025.
- Over 5 years, Assets Average stood at $15.4 million in 2022, then fell by 11.84% to $13.6 million in 2023, then declined by 0.51% to $13.5 million in 2024, then declined by 1.05% to $13.4 million in 2025, then jumped by 34.57% to $18.0 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $18.0 million, $13.4 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Quoin Pharmaceuticals | 542,031.05 | 542,031.05 | - | 13.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.04 Mn |
| Dec 31, 2025 | 13.41 Mn |
| Sep 30, 2025 | 7.67 Mn |
| Jun 30, 2025 | 10.93 Mn |
| Mar 31, 2025 | 14.33 Mn |
| Dec 31, 2024 | 13.55 Mn |
| Sep 30, 2024 | 12.72 Mn |
| Jun 30, 2024 | 15.09 Mn |
| Mar 31, 2024 | 14.15 Mn |
| Dec 31, 2023 | 13.62 Mn |
| Sep 30, 2023 | 15.89 Mn |
| Jun 30, 2023 | 17.58 Mn |
| Mar 31, 2023 | 16.45 Mn |
| Dec 31, 2022 | 15.45 Mn |
| Sep 30, 2022 | 10.38 Mn |
| Dec 31, 2020 | 4.67 Mn |
| Jun 30, 2020 | 8.35 Mn |
| Jun 30, 2019 | 7.12 Mn |
| Dec 31, 2018 | 7.24 Mn |
| Jun 30, 2018 | 8.87 Mn |